Fortrea's Participation in the Jefferies Global Healthcare Conference
Fortrea (Nasdaq: FTRE), recognized as a leading global contract research organization (CRO), is set to showcase its industry expertise at an imminent healthcare conference. The company's Chairman and Interim Chief Executive Officer, Peter M. Neupert, alongside Chief Financial Officer, Jill McConnell, will be making a presentation at the Jefferies Global Healthcare Conference. This significant event is scheduled for Thursday, June 5, 2025, at 8:45 am ET, where they will discuss the company’s innovative advancements and strategies.
Accessing the Live Webcast
For those interested in Fortrea's insights, a live webcast will be made accessible through the company's Investor Relations website. This platform will provide a valuable opportunity for stakeholders and potential investors to hear directly from the leadership about current initiatives and future outlooks of the company. A replay of the webcast will be available shortly after the live presentation, ensuring that those who cannot attend live still have access to crucial information.
About Fortrea
Fortrea stands out in the life sciences sector as a premier provider of clinical development solutions. The organization's mission is to partner with both emerging and established biopharmaceutical, biotechnology, medical device, and diagnostic firms. By doing so, Fortrea aims to propel healthcare innovation that leads to life-altering therapies for patients around the globe. The company is involved in comprehensive phase I-IV clinical trial management, clinical pharmacology, and consulting services, which are tailored to meet the unique needs of its diverse client base.
The Impact of Expertise and Experience
With a robust history of over three decades, Fortrea's commitment to delivering scientific excellence is evident. Their extensive experience covers more than 20 therapeutic areas, underscoring their capability to handle a wide range of clinical challenges effectively. This dedication to scientific rigor, coupled with valuable insights and a comprehensive network of investigator sites, positions Fortrea as a transformative force in the healthcare landscape.
A Diverse Global Presence
Fortrea operates in approximately 100 countries, which allows them to provide focused and agile solutions to clients worldwide. The company's talented and diverse team works diligently to adapt to the needs of the healthcare industry, driving innovation and ensuring that therapies reach those who need them most. Their global footprint enhances their ability to serve a wide range of medical needs, making them a pivotal player in the clinical development space.
The Future of Healthcare with Fortrea
As Fortrea continues to evolve, they emphasize not just the importance of clinical trials but the overarching goal of enhancing patient outcomes through effective healthcare solutions. At the conference, leadership is expected to articulate how they plan to navigate upcoming challenges in the industry while maintaining their commitment to quality and patient care. By focusing on innovative solutions, Fortrea aims to be at the forefront of clinical development.
Frequently Asked Questions
What is Fortrea known for?
Fortrea is known for being a leading global contract research organization that provides clinical development solutions to the life sciences industry.
Who will be presenting at the Jefferies Global Healthcare Conference?
Peter M. Neupert, the Chairman and Interim Chief Executive Officer, and Jill McConnell, the Chief Financial Officer of Fortrea, will be presenting.
When is the Jefferies Global Healthcare Conference taking place?
The conference is scheduled for Thursday, June 5, 2025, at 8:45 am ET.
How can I access the live webcast of the conference?
The live webcast can be accessed through Fortrea's Investor Relations website.
What areas does Fortrea specialize in?
Fortrea specializes in phase I-IV clinical trial management, clinical pharmacology, and consulting services across over 20 therapeutic areas.
